Skip to main content

Global AI in Ultrasound Imaging Market to Expand at 22% CAGR, AI-Driven Image Accuracy in Focus by 2030

 


The global AI in ultrasound imaging market is set to witness a growth rate of 22% in the next 5 years. Growing adoption of AI for image analysis & interpretation, increasing prevalence of chronic diseases, shortage of skilled radiologists & sonographers, growing demand for point-of-care ultrasound (POCUS), and increasing integration of AI with cloud & edge computing are some of the key factors driving the AI in ultrasound imaging market.

AI in ultrasound refers to the integration of artificial intelligence, including machine learning and deep learning, to enhance image acquisition, interpretation, and diagnostics. AI algorithms automate image segmentation, anomaly detection, and workflow optimization, improving accuracy and efficiency. It aids in real-time decision-making, reduces dependence on highly skilled radiologists, and enhances point-of-care applications. AI-powered ultrasound is widely used in cardiology, obstetrics, oncology, and musculoskeletal imaging. By integrating cloud and edge computing, AI enables remote diagnostics and telemedicine applications, making ultrasound more accessible and effective in diverse healthcare settings.

Discover the more details-Download the PDF brochure:
https://meditechinsights.com/ai-in-ultrasound-imaging-market/request-sample/

Growing adoption of AI for image analysis & interpretation to propel market demand

The growing adoption of AI for image analysis and interpretation is a major driver of the AI in ultrasound market. AI enhances image acquisition, automates segmentation, and improves anomaly detection, leading to faster and more accurate diagnoses. Deep learning algorithms reduce human errors and assist less experienced clinicians in making precise assessments. AI-powered ultrasound streamlines workflows, reducing scan time and improving efficiency in hospitals and clinics. Additionally, AI-driven real-time analysis supports early disease detection in cardiology, oncology, and obstetrics. As demand for improved diagnostic accuracy rises, AI-integrated ultrasound systems are increasingly adopted, fueling market growth.

Growing demand for point-of-care ultrasound (POCUS) is driving the market growth

The growing demand for point-of-care ultrasound (POCUS) is significantly driving the AI in ultrasound market. POCUS is widely used in emergency care, intensive care units, and remote settings for rapid, bedside diagnostics. AI enhances POCUS by automating image acquisition, interpretation, and anomaly detection, enabling faster and more accurate decision-making. AI-powered handheld ultrasound devices improve accessibility, especially in rural areas with limited radiologists. Additionally, AI-driven real-time guidance helps less-experienced clinicians perform scans with higher precision. As healthcare systems prioritize efficiency and accessibility, AI-integrated POCUS devices are increasingly adopted, boosting market growth and expanding ultrasound applications.

Competitive Landscape Analysis

The global AI in ultrasound imaging market is marked by the presence of established and emerging market players such as Koninklijke Philips N.V., Siemens Healthineers, GE Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, Butterfly Network, Inc, Fujifilm Holdings, Ultrasound AI Inc., Clarius, and MedSol AI Solutions; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Unlock key findings! Fill out a quick inquiry to access a sample report
https://meditechinsights.com/ai-in-ultrasound-imaging-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global AI in ultrasound imaging market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, application, end user.

  • Market Size & Forecast (2023-2030), By Product, USD Million
    • Software
    • Service
  • Market Size & Forecast (2023-2030), By Application, USD Million
    • General imaging
    • Cardiology
    • Obstetrics & Gynaecology (OBGY)
    • Oncology
    • Urology
    • Others
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Hospitals
    • Diagnostic Imaging Centers
    • Ambulatory Surgical Centers (ASCs)
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more